The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism

• Status: Completed
• Trial end date: 2014-04-01
• Target enrollment: 0
• Participant gender: Male

Summary

The study is designed to answer the following questions:

1) What is the effect of testosteron replacement treatment on the endothelial dysfunction.

2/ What is the effect of testosteron replacement on the bone mineral metabolism.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Gulhane School of Medicine
• Treatments: Methyltestosterone; Mitogens; N,N-dimethylarginine; Testosterone; Testosterone 17 beta-cypionate; Testosterone enanthate; Testosterone undecanoate; Vitamin D

Criteria

Inclusion Criteria:

• Men

• Congenital hypogonadism

• Treatment Naive

Exclusion Criteria:

• Previous history of androgen replacement

• Hypertension

• Diabetes mellitus